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Summary
In previous studies we demonstrated that, following activation by mitogens or alloantigens, helper
T cell precursors proliferate and differentiate in vitro to produce a population of effector cells
that secrete high titers of lymphokines upon restimulation . In this report, we demonstrate that
a similar effector population develops in vivo following primary antigen stimulation . When
restimulated with specific antigen in vitro, CD4+ T cells from mice primed 5 to 7 days
previously by subcutaneous administration of keyhole limpet hemocyanin (KLH) in adjuvant,
produced high levels of interleukin 2 (IL2), IL4, and IL3, and little or no interferon y (IFN-'y)
or IL-5 . The effector T cells provided excellent helper activity for in vitro antibody responses
of 4-hydroxy-5-iodo-nitrophenyl acetic acid-primed B cells with the production principally of
the immunoglobulin Gt (IgGI) and IgM isotypes, small quantities of IgG3, and no detectable
IgG2a, or IgG2b. Antigen-specific secretion of 11,2, IL-3, and ILA by in vivo effectors was detectable
by 12 hours following in vitro restimulation . IFN-y and IL5 were not detected until 48 and
72 hours of culture, respectively, and low levels ofthese lymphokines were produced . Lymphokine
production by primed CD4+ T cells could be induced as early as 3 days following immunization,
peaked on day 5, and declined thereafter. The kinetics of in vivo appearance of effector CD4+
T cells that produce lymphokines upon restimulation in vitro were similar for each of the
lymphokines examined .
Mice depleted of precursor CD4+ T cells by adult thymectomy exhibited limited capacity
to generate lymphokine secreting CD4+ T cells in response to primary immunization with
KLH, suggesting that the majority of lymphokine producingT cells arise from short-lived and/or
precursor cells. Separation ofCD4+ T cells from KLH-primed mice on the basis of expression
of the lymph node-specific homing receptor, MEL14, revealed that antigen-specific production
of IL-2, IL-3, IL4, and IFN-y was exclusively associated with the MEL14 - subset of CD4+
T cells . Separation on the basis of CD45RB expression, demonstrated that antigen-specific
lymphokine production was primarily associated with the minor CD45RB - population, which
has been previously associated with memory activity. Our results indicate that primary in vivo
immunization leads to the development ofa transient population of helper-effectors with a unique
phenotype that can produce large quantities of lymphokines and mediate excellent helper activity
for B cells. This population may be of critical importance for in vivo regulation of the immune
response.
T
he immune response of an animal to an antigen that it
has not previously encountered depends upon the statisti-
cally unlikely interaction of two rare antigen-specific cells :
a helper T cell and a B cell which must each recognize for-
eign determinants on the same molecule . It has been sug-
gested that the CD4+ helper T cell and B cell initially en-
counter antigen separately and then selectively migrate to
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specialized areas in secondary lymphoid organs where they
have an increased likelihood of engaging in the interactions
necessary for an effective B cell response. The response of
the B cell depends both on the direct interaction of the B
cell with the T cell and on the lymphokines produced by
the T cell . Optimal B cell proliferation and differentiation
into Ab-secreting cells requires several lymphokines produced
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(1) . The generation ofisotype switch inB cells requires quite
high concentrations of 114 or IFN-y for the respective switch
to IgG1/IgE versus IgG2a. Paradoxically, despite the obvious
importance of such lymphokines, naive CD4' T cells are
able to synthesize and secrete only IL2 in direct response to
stimulation (2) and even resting memory CD4+ T cells
make relatively low quantities oflymphokines other than IL-2
(3-5) in comparison to cloned T cell lines which are very
effective helpers and make prodigious quantities of lym-
phokines such as 11A 1175, IL-6, and IFN--y (1, 6) .
Recently, we found that CD4+ T cells with the pheno-
type and characteristics of naive precursor cells, proliferate
and differentiate in vitro in response to alloantigens or mitogens
to generate a population of cells in 3-4 d which, when re-
stimulated secretes very high titers of IL4, IL-5, and IFN--y
(3) . We call these cells effectors by analogy with CTL devel-
opment . If such cells are also generated during an in vivo
in response to antigenic challenge and relocate appropriately,
they could potentially act as very efficient populations of
helpers for B cells during the primary immune response and
could also mediate isotype switch . Therefore, we undertook
an investigation of whether an effector population secreting
lymphokines in addition to IL2 would develop in vivo in
response to immunization with conventional antigens and
sought to determine its origin, lymphokine secretion profile,
kinetics of development, and phenotype .
Previous studies of the regulation of lymphokine produc-
tion by T cells have often used in vitro models of polyclonal
activation and/or cloned in vitro cell lines . Therefore, very
little is known about the characteristics and phenotype of
lymphokine-secreting helperT cells that develop in vivo during
animmune response . In addition, many ofthe previous studies
investigating the development of antigen-specific CD4' T
cells from immunized animals have used limiting dilution
analysis combined with in vitro selection to generate clones
of T cells (4, 7-10) . Because lymphokine production is ex-
amined only after additional in vitro expansion, the kinetics
of the response and phenotype of the cells which develop
during primary immune responses in vivo have not generally
been addressed. Several reports have stressed that IL4 produc-
tion requires one or more rounds of restimulation (3-5, 11,
12), although recent studies do suggest that both 11,2 and
114 production may occur in vivo during the first 5 d fol-
lowing exposure to antigen (13) and high levels of11,4 produc-
tion have been detected following infection with parasites
(14, 15) .
In this report, we examine the kinetics of in vivo develop-
ment of antigen-specific CD4' T cells which arise in re-
sponse to primary immunization with KLH and characterize
the lymphokines that are produced, the cells that produce
them, and the cells from which they were derived. We find
that antigen-specific CD4' T cells with the capacity to
mediate helper activity and to produce high titers of lym-
phokines, including 1164, in response to restimulation develop
after priming with a standard immunization regimen with
similar kinetics to lymphokine secreting effectors generated
in vitro. Development ofCD4' effector cells in response to
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a primary injection of antigen is dependent upon a popula-
tion of precursor T cells that is largely depleted in adult
thymectomized mice . We also examine the surface pheno-
type of the antigen-specific effector population in terms of
expression of MEL14, the lymph node specific homing
receptor that is down-regulated in vitro following polyclonal
activation ofT cells (16), and ofCD45RB(23G2), which ap-
pears to distinguish virgin from memory CD4' T cells (17)
and can also be down=regulated following in vitro activation
of CD4+ T cells (18) . These studies provide detailed char-
acterization of effector helperT cells able to secrete high titers
oflymphokines that are generated in vivo during an immune
response.
Materials and Methods
Mice. BALB.B and C57BL/6, and (C57BL/6 x DBA/2)F l
hybrid (BDF,) mice were bred in ourown facility from pedigreed
breeders obtained from theJackson Laboratories (Bar Harbor, ME) .
Adult mice of the same age were used in individual experiments .
Reagents.
￿
KLH was purchased from Calbiochem (LaJolla, CA),
OVA, pigeon cytochrome C (Cyt C), 1 and BSA were obtained
from Sigma Chemical Co. (St . Louis,MO) . NIP (4-hydroxy-5-iodo-
nitrophenyl acetic acid) (Cambridge Research Biochemicals, Valley
Stream, NY) was conjugated to OVA, KLH, CytC, or BSA as
previously described (19) . Medium for all in vitro cultures wasRPMI
1640 (Irvine Scientific, Santa Ana, CA) supplemented with 200
ttg/ml penicillin, 200 hg/ml streptomycin, 4 MM L-glutamine, 10
mM HEPES, 5 x 10-5M 2-ME, and 7% FCS (Hyclone Labora-
tories, Logan, UT) .
Immunizations.
￿
To generate primed CD4' T cells, mice were
immunized subcutaneously at the base of the tail with 250 RgKLH
or OVA emulsified in either complete or incomplete Freund's adju-
vant (Difco Laboratories, Detroit, MI) . Draining periaortic lymph
nodes were removed at various times after immunization and used
as a source ofT cells. Hapten-primed B cells were obtained from
mice that were initially immunized by i.p. injection of 100 ug NIP-
OVA precipitated with 1.8 mg alum together with 10' heat-
inactivated Bordetella pertussis organisms. After 2 to 4 mo, mice were
boosted intravenously with 20 ug soluble NIP-OVA and B cells
were isolated from the spleens 10 to 14 d later.
Antibodies .
￿
The antibodies for depletion ofcell populations have
been previously described (3) and include antiThy-1.2 (F7D5 and
HO.13.14), anti-Ly 2.2 (HO.2.2), anti-L3T4 (RL172.4), and anti-
Class II (D3.137) (a kind gift ofDr. Susan Tonkonogy, North Caro-
lina State University, Charleston, NC) . Fluoresceinated (FL)-anti-
Ly 2 (anti-CD8) and phycoerythrin labeled (PE)-GK1 .5 (anti-CD4)
were obtained from Becton Dickinson and Co. (Mountain View,
CA) . Pgp-1 (anti-CD44) .(20), 23G2 (a kind gift of Dr. Ellen Pure,
Rockefeller University, New York, NY) (18) and MEL14 (21) cell
lines were cultured to generate antibodies used in indirect im-
munofluorescence with FILRG7/9/1 (mouse anti-rat tc) to detect
subsets ofCD4' T cells . Goat anti-mouse isotype-specific anti-
bodies labeled with horseradish peroxidase for the ELISA assay of
NIP-specific antibody from in vitro secondary anti-hapten responses
were purchased from Southern Biotechnology Associates (Bir-
mingham, AL) . The following antibodies were obtained as ascites
1 Abbreviations used in this paper . Cyt C, Cytochrome C ; MFI, mean
fluorescence index ; NIP, 4-hydroxyl-5-iodo-nitrophenyl acetic acid .from nude mice as previously described (22) : 11B11 : anti-IL4; 7134
andPC.61 : anti-IL2R, TRFK4andTRFK5: anti-11,5, andR46A2
and XMG1.2 : anti-IFN-,y .
Recombinant Lymphokines. Human rIL2 was obtained from
Cetus Corporation (Emeryville, CA). Murine rIL3 was obtained
fromGenzyme (Boston, MA). Murine rIFN-y wasobtained from
Amgen Biologicals (Thousand Oaks, CA) . rIL4 and rIL5 were
obtained from the culture supernatants of the X63.Ag8-653 line
that was transfected with the murine cDNA for IL-4 or for IL5,
respectively (23) . The IL4 and IL5 secreting lines were the kind
gift ofDr. Fritz Melchers (Basel Institutes forImmunology, Basel,
Switzerland) .
ectomy.
￿
BDF I or C57BL/6 mice were thymectomized by
suction at 8wk ofageor older. At thetime ofsacrifice, mice were
checked for thymic remnants and spleen cells were stained for cells
that coexpressCD4 andPgp-1which are enriched in thymectomized
mice (3) . Thymectomized mice were compared to untreated con-
trol mice of the same age and strain .
Preparation ofCD4' TCells.
￿
Periaortic lymph node cells {rom
mice immunized with KLH or OVA in adjuvant were depleted
ofB cells by treatment at 2 x 10' ml with 0.5 FAg/ml biotinylated
rat anti-mouse is (Pharmingen, SanDiego, CA) for30 min at 4°C,
followed by incubation with Streptavidin-coated magnetic parti-
cles (Advanced Magnetics, Cambridge, MA) at a 40 :1 ratio for an
additional 30 min at 4°C . Surface Ig positive cells were depleted
by three 10-min cycles of exposure to a magnetic field . The re-
maininglymph node cells were further enriched forCD4* T cells
by treatment with antiJ11D, 133.137, and Ly 2.2 antibodies and
a combination of guinea pig (Gibco Laboratories, Grand Island,
NY)and rabbit complement (AccurateChemical and Scientific Cor-
poration, Westbury, NY) to deplete CD8' T cells and residual
B cells. The resulting populations were 80 to 90% CD4' T cells .
Magnetic Activated Cell Sorter (MACS) Separation ofCD4' T
Cells . Subsets ofCD4' T cells were prepared by magnetic sepa-
ration with a MACS column (Miltenyi Biotech, Germany) (24).
Enriched CD4' T cells were sequentially stained with either
MEL14orCD45RB (23G2), biotinylated-RG7/9/1, Fl-Strepavidin,
and biotinylated magnetic particles, according to the manufacturer's
instructions. The positively staining population was retained by
the MACS column in the presence of the magnetic field, while
the negative population was eluted . Populations were checked for
purity by flow cytometryandreincubatedon thecolumn as neces-
sary to achieve maximum separation of the positive and negative
subsets . Due to washing of the columns during retention of the
positive population, as well as sequential passages ofboth the posi-
tive and negative populations over thecolumn, generally30 to50%
ofthe initial stained population was recovered following the isola-
tion procedure.
Preparation ofB Cells andAPC .
￿
T cells were depleted from
normal or antigen-primed spleen cell populations by treatmentwith
a cocktail of directly cytotoxic antiT cell reagents (two antiThy
1.2 antibodies, anti-CD4, and anti-CD8) and complement . The
resulting populations consisted of >95% surface Ig' cells. Tde-
pleted spleen cells from normal animals were used as a source of
APCs for the induction of lymphokine production by antigen-
primed CD4' T cells. In some experiments, the APCs were
pulsed with antigen by overnight culture in the presence of 100
,ug/ml of either OVAor KLH. T -depleted spleen cells from NIP-
OVAprimed mice were used as a source of antigen-primed B cells
to assay helper activity of KLH-primed CD4' T cells .
Flow Cytometry .
￿
Lymphoid populations (106) were stained by
incubation with antibody for 30 min at 4'C in PBS containing
5% FCS and 0.5% NaN3, washed, and fixed with 1% methanol-
549
￿
Bradley et al.
free formaldehyde in PBS. In the case of double staining, cells were
incubated with an unlabeled first step antibody, followed by FL
RG7, and finally with PE-conjugated anti-CD4 . 5 x 103 cells
were analyzed using a FACSCAN flow cytometer (Becton Dick-
inson and Co.) .
In Vitro Stimulation ofLymphokine Production by CD4' TCells.
CD4* lymph nodes from KLH-primed mice were cultured in ei-
ther 0.75 ml or 1.5 ml volumes in 48 or 24 well plates, respectively,
at 10 6/ml (or at concentrations indicated in the text for individual
experiments) together with 106/ml APC. The cultures were im-
munized with 75 ug/ml KLH, or an identical concentration of
the irrelevant antigen, OVA. In some experiments antigen-pulsed
APC were used (see above) . Culture supernatants were harvested
after 24 to 36 h, unless otherwise indicated . Culture supernatants
were stored at -20°C before testing for lymphokine content .
Assays ofLymphokine Production .
￿
The bioassays used for detec-
tion oflymphokines in the culture supernatants ofantigen-primed
CD4* T cells have been previously described (3, 22) and are briefly
summarized below . In all assays, serial two-fold dilutions of test
supernatants, starting at 1:10, were added to triplicate cultures of
indicator cells in 0.1 ml volumes in 96-well plates (Costar, Cam-
bridge, MA) . The data are quantitated from standard curves gener-
ated using serial two-fold dilutions of control recombinant lym-
phokines. The data are expressed as U/ml, where 50% of the
maximal response represents the activity of 1 U . U/ml are calcu-
lated from the reciprocal of the dilution that gives half maximal
activity, divided by the culture volume. For proliferation assays,
indicator cells were cultured with test supernatants or control lym-
phokines for 48 h and pulsed with ''I-UdR during the last 16 h
ofincubation . Cultures were harvested onto glass fiber filter paper
using a multiple sample harvester, and counted with a gamma
counter.
IL2 and 11,4 in T cell culture supernatants was detected using
theNK cell line, which responds to both lymphokines. To detect
IL2, IL4 activitywas inhibited by the addition ofthe 11B11 anti-11J4
antibody at 1.0,ug/ml . To detect IL4, IL2 activity was inhibited
by the addition of 1.0,ug/ml each of two anti-IL2R antibodies,
PC.61 and 7134 . Theanti-IL4 and anti-IL2R antibodies together
completely blocked proliferation in response to test supernatants .
In this assay, maximum levels of NK cell proliferation were ob-
tained with 2 U/culture (3 pg) of rIL2, and 3 U/culture{45 pg)
of rIL4 . The 11B11 antibody blocks up to 30 U/culture of IL-4
without affecting the IL2 response, and the PC.61 and7134 anti-
bodies block up to 12 U/culture of IL2 without inhibiting the
IL4-response (not shown) .
IL3 in test culture supernatants was detected by the prolifera-
tion of the 32Dc15 line, which does not respond to other lym-
phokines under the conditions of our experiments (3). Maximum
proliferationwas obtained with 3 U/culture (3pg) of rIL3 as defined
by Genzyme.
111,5 and IFN-y were detected by ELISA assay. Polyvinyl chlo-
ride 96-well plates (Falcon, Oxnard, CA) were coated overnight
with 1.0 /~g/ml TRFK.5 anti-IL5 or R46A2 anti-IFN-y anti-
bodies, respectively, in PBS pH 7.4 and blocked with PBS con-
taining10% FCS, 1% BSA, 0.05% Tween 20 for30min at 37°C.
The plates were washed and incubated with dilutions of culture
supernatants and control rIL5 and rIFN-y for 1 h at 37°C. The
plates were then incubated sequentially with : biotinylatedTRFKA
anti-11,5 or XMG1.2 anti-IFN-y for 1 h at room temperature;
peroxidase-labeled streptavidin for 1 h at room temperature ; and
100 ttg/ml O-phenylenediamine dihydrochloride and 200 Jig/ml
urea hydrogen peroxide in citrate phosphate buffer for 30 min at
room temperature . The plates were washed between steps. The reac-tion was stopped by the addition of H2SO4 in a final concentra-
tion of 5%, and the plates were read at 492 nm using a Titertek
Multiskan MCC/340ELISA reader (Flow Laboratories, McLean,
VA) . IL5 and IFN-y present in individual culture supernatants were
quantitated bycomparison to standards containing rIL5 and rIFN--y .
1U of rIFN-y as defined by Amgen Biologicals equals the quan-
tity required to neutralize viral destruction of L929 cellsby 50%
and the limit of detection in the IFN-y ELISA is 0.5 ng/ml
(5 U/ml). 1U of X63.Ag8-653 IL5 is equivalent to 1U of rIIL5
as defined by Genzyme as theamount required to induce halfmax-
imal proliferation ofdextran sulfate-stimulated B cells and the limit
of detection in the IL5 ELISA is 2 ng/ml (2 U/ml) .
Measurement ofHelper Activity of In Vivo Primed CD4' T
Cells . T -depleted spleen cells from NIPOVA primed mice were
culture in duplicate at 1.25 x 106/ml together with KLH-primed
CD4 * T cells, as indicated in the text, in 0.7 ml volumes in 48-
well plates (Costar) . The cultures were immunizedwith 0.03,ug/ml
NIP-KLH, or with the same doses of NIP-OVA or NIP-CytC .
After 7 d, the culture supernatants were harvestedand assayed for
the presence of NIP-specific antibodies with an antigen and iso-
type specific ELISAusing NIP-BSA-coated plates and horseradish
peroxidase-labeled goat anti-mouse antibodies specific for IgM,
IgG1, IgG3, IgG2a, andIgG2b . Anti-NIP antibody present in in-
dividual culture supernatants was quantitated in comparison to an
anti-NIP sera generated in BALB.B mice . Standard curves were
generated using serial two-fold dilutions of the sera starting at 1:400
for IgM, IgG3, IgG2a, andIgG2b, and at 1:3200 for IgG1 . These
dilutions for the individual isotypes were assigned a value of
1,000 U/ml .
Results
In Vivo Induction of Antigen-speck CD4+ Lymphokine-
secreting T Cells. To study the in vivo induction of lym-
phokine producing T cells, mice were immunized s.c . with
KLH in CFA. 5 to 7 d after immunization, CD4+ T cells
were enriched from thedraining periaortic lymph nodes and
cultured at varying concentrations together with 106/ml
mitomycin-treated, T cell-depleted spleen cells from normal
animals as a source ofAPC, and with either OVA or KLH.
The supernatants were harvested after 24 h and tested for
thepresence of IL2, IL3, IL4, IL5, andIFN--y . Stimulation
with KLH resulted in production of IL2, IL3, and IL4 by
the primed CD4+ T cells as shown in Fig . 1 A . Stimula-
tion with OVA did not lead to lymphokine production, in-
dicating both that the cells required restimulation to pro-
duce lymphokines and that the response was specific for the
priming antigen, KLH. IFN-y titers in the same superna-
tants were less than 20 U/ml and 1175 was less than 5 U/ml
(not shown) . Comparable results have been obtained in over
five separate experiments. Similar results were obtained when
mice were primed and challenged with OVA in CFA, and
when antigen was administered in IFA although the magni-
tude of theresponses were less (not shown) . No lymphokine
production was obtained in the absence of added APC, and
no detectable lymphokineswere produced by theAPC popu-
lation alone in response to KLH (not shown) . In each bio-
assay, all of the supernatant activity was blocked by appro-
priate Ab to the relevant test lymphokine, demonstrating the
specificity of the assays (not shown) . KLH at doses from
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Figure 1 . IL2, IL-3, and 114 production by CD4+ KLH-primed
T cells . (A) CD4+ lymph node T cells from BDF1 mice primed 5 d pre-
viously withKLH inCFAwere highly enriched forCD4+ T cells as de-
scribed in the Materials andMethods. Before culture the cells were stained
by indirect immunofluorescence with theindicated antibodies and followed
by FITC-RG7/9/1, (anti-rat is chain antibody) and contained90% GK1.5
(CD4+) cells, 7.4% Ly2.2 (CD8+) cells, and 11.4% Bet-2 (slgM+) cells.
The indicated numbers of cells were cultured with 106 APC and either
KLH or OVA . Culture supernatants were harvested at 24 h and tested
for the presence of IL2, 11,3, 114, 11,5 and IFN-y as described in the
MaterialsandMethods. Less than 20 U/ml of IFN-'Y and 5 U/ml of IL5
were detected (not shown). (B) Helper activity of KLH-primed CD4+
T cells . CD4+ lymph nodeT cells were isolated from BALB.B mice 5 d
after immunization with KLH and combined in various concentrations
with NIP-OVA primedB cells and either NIP-KLH or NIP-Cyt C. After
7 d, supernatants from duplicate cultures were harvested and assayed for
anti-NIP antibodies using an isotype-specific ELISA as described in the
Materials and Methods.
50-100 NAg/ml were found to be optimum for stimulating
lymphokine production (not shown) .
It should be noted that immunization with CFA alone
resulted in detectable levels of 11,2 and IL3 (that typically
comprise 10-30% of theresponse), but not of 11,4, 11,5, or
IFN-y in cultures stimulated with KLH-pulsed APCs (not
shown) . Since no detectable lymphokines were produced byeither adjuvant- or KLH-primed CD4+ T cells to OVA,
these results suggested that CFA-priming generates a small
population ofT cells crossreactive with KLH . Indeed, when
mice were primed with IFA, the adjuvant effect in terms of
IL2 and 11,3 production to KLH was eliminated (not shown) .
The majority of the lymphokine producing activity was
present in the draining periaortic lymph nodes, although small
responses could also be obtained with CD4+ T cells isolated
from inguinal lymph nodes (our unpublished observations) .
We examined the capacity ofKLH-primed CD4+ T cells
to mediate helper activity in secondary in vitro anti-hapten
responses. CD4+, KLH-primed T cells were isolated at 5 d
after immunization and combined withT -depleted spleen cells
from mice that were primed and boosted with NIP-OVA as
a source ofB cells. The cultures were immunized with NIP-
KLH, and supernatants were harvested after 7 d of incuba-
tion . The presence of NIP-specific antibody was measured
by an antigen- and isotype-specific ELISA . The results, shown
in Fig . 1 B, indicate that the short-term primed CD4+ T
cells provided excellent helper activity for B cells and that
IgG1 and IgM are predominant isotypes of anti-NIP anti-
body produced under the conditions of the experiment. The
presence ofhelper activity for these isotypes is dependent upon
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priming : no antibody production was observed when cul-
tures were immunized with NIP conjugated to the irrele-
vant carrier, Cyt C (data not shown). The KLH-primed,
CD4 * T cell used in this experiment were tested for lym-
phokine production and 1.5 x 10 6 cells secreted 530 U/ml
11,2 and 500 U/ml 114 .
Kinetics of In Vitro Lymphokine Secretion byKLHprimed
CD4 -' T Cells . We examined the in vitro kinetics of lym-
phokine production following specific restimulation ofKLH
primed CD4+ T cells . The results shown in Fig. 2 demon-
strate that IL2, IL3, and 11,4 could be detected in superna-
tants by 12 h following restimulation with KLH in culture.
In contrast, IFN-y and 11,5 were not detected until 48 and
72 h, respectively, and only low levels of these lymphokines
were observed (note the different scales of the graphs) . Since
low levels ofIFN-y can be detected by the ELISA, andIFN-y
could be readily measured in 36-h supernatants when the
lymphokine-secreting population was enriched (see below),
the apparent delayed production of this lymphokine presum-
ably reflects accumulation of sufficient levels for detection .
In contrast, 11,5 was not detected in supernatants collected
at 48 h or earlier, evenwhen the lymphokine-secreting popu-
lation was enriched (see below) probably because the ELISA
IL-5
Hours of Culture
IL-4
12 24 38 48 72
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Figure 2 .
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In vitro kinetics oflymphokine production by KLH-primed CD4+ T cells. CD4+ lymph nodeT cells were isolated from C57BL/6 mice
from mice primed with KLH 5 d previously, and cultured with APC and KLH as described for Fig. 1. Culture supernatants were harvested at the
indicated times, and assayed for the presence of 11,2, 11,3, IL4, IFN--y, and IM .assay for IL5 is relatively insensitive (see Materials and Meth-
ods) . The results indicate that in vivo priming with KLH
generates a population of CD4+ T cells that secretes pre-
dominately IL-2, IL3, IL4, andIFN-y and possibly low titers
of IL5, regardless of the time after in vitro restimulation .
There was a drop in IL2 found in culture supernatants at
72 h, presumably as a result of IL2 uptake by responding
cells. In subsequent experiments, lymphokines were harvested
from 12 to 36 h to minimize the influence of uptake on the
results.
Kinetics ofIn Vivo DevelopmentofKLH-specficLymphokine-
secreting T Cells. To further characterize the development
of antigen-specific lymphokine secreting T cells which de-
velop in vivo, lymphokine production by enriched CD4+ T
cells, isolated from thelymph nodes ofKLH-primed animals
at various times after immunization was determined . Super-
natants were collected from replicate cultures after 12 and
Kinetics of In Vivo Development of KLH-Specific Effector CD4+ T Cells
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24 h and assayed for IL2, IL4, IL3, IL-5 and IFN--y . The
results for 24-h supernatants shown in Fig . 3 are representa-
tive of three of the experiments in which the kinetic devel-
opment of CD4+ T effector cells was determined . 12-h su-
pernatants had lower levels oflymphokine activity but showed
the same patterns (not shown) . Lymphokine secretion was
detectable as early as 3 d after immunization, peaked at days
5 to 7, and declined steadily thereafter. Similar kinetics were
observed for the development ofCD4+ T cells with the ca-
pacity to produce 1172, IL3, IL4, and IFN-y and no IL5
was detected under the conditions of these experiments . Lym-
phokine-secreting CD4+ T cells that develop in response to
ix. administration ofSRBC exhibit similar kinetics, but pro-
duce primarily IL2 and IL3, moderate amounts of IL4, and
IFN-y and no detectable IL5 (not shown) .
Antigen-s ecfic CD4+ Lymphokineproducing Cells Develop
from Short-lived Precursors.
￿
In previous studies, we demon-
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Kinetics of lymphokine production by CD4+ KLH-primedT cells . CD4+ lymph node T cells were isolated from BALB.B mice at the
indicated times after immunization with KLH in CFA and cultured at 106/ml with an equal number of APC and either OVA (data not shown) or
KLH . Culture supernatants were harvested from replicate cultures at either 12 or 24 h and tested for IL2, IL3, IL4, 116, or IFN-y activity as described
for Fig. 1. No lymphokines were detected in the supernatants of KLH-primed CD4+ cells cultured with OVA (not shown) . No IL-5 was detected
(not shown) .strated that CD4+ T cells activated in vitro with mitogens
or allogeneic cells develop in the presence ofexogenous lym-
phokines (IL-2 and IL4) into effector cells that produce high
titers of lymphokines (IL3, IL4, 116, and IFN-y) upon re-
stimulation (3, 22) . Development ofthe in vitro effector popu-
lation depends upon CD4+ T cells that express low levels
of the homing receptor, Pgp-1, and are depleted from the
spleen by adult thymectomy . To determine if the antigen-
specific CD4+ T cell population that is induced in vivo is
Development of KLH-Specific Effector CD4+ T Cells
is Reduced in Thymectomized Mice
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Figure 4.
￿
Effect of thymectomy on lymphokine production byCD4`
KLH-primed T cells. CD4+ lymph node T cells were isolated from con-
trol and thymectomized C57BL/6 mice that were immunized 5 d previ-
ously with KLH and cultured at 106/ml with an equal number of APC,
and either OVA (data not shown) or KLH. Culture supernatants were
harvested at 24 h and tested for the presence oflymphokines . Shown are
11,2, 11,3, 114 produced by CD4+ T cells from control versus thymec-
tomized mice. Low levels of IFN --y production (8 U/ml) were detected
only from the highest concentration of cells from control animals . No
H,5 was detected, and nolymphokines wereproduced in cultures immunized
with OVA (not shown) .
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derived from similar precursor T cells, we compared the de-
velopment of antigen-specific CD4+ lymphokine secreting
cells in control (age-matched) and adult thymectomized mice
(6 mo after thymectomy) .
Although no differences in Pgp-1 expression by CD4+
lymph node cells from normal and KLH-primed mice could
be detected (not shown), the CD4+ T cells from adult
thymectomized mice exhibited dramatically increased levels
of Pgp-1 : CD4+ T cells from control animals displayed a
single broad peak of fluorescence with a mean log fluores-
cence intensity (MFI) of 16.6, . while those from thymec-
tomized mice exhibited 2 peaks of fluorescence with MFI
values of 35.4 and 275.6. CD4+ T cells comprised 38% of
the lymph node population of control animals, and 15% of
the lymph node cells from thymectomized animals. CD8+
T cells and surface Ig+ cells were comparable in control and
thymectomized mice (19% vs . 26% Ly2+, 17% vs. 22%
Ig+, respectively), confirming that thymectomy causes a
selective reduction in CD4+ T cells that express low levels
of Pgp-1, and that presumably represent the naive CD4
precursor population.
We examined the effect ofthymectomy on the in vivo gener-
ation of antigen-specific CD4+ lymphokine secretingT cells
by comparing in vitro lymphokine production by CD4+
lymph node cells from control and thymectomized animals
5 d after immunization with KLH . The results shown in
Fig. 4 demonstrate that CD4+ T cells derived from thymec-
tomized mice are deficient in the antigen-induced effectors
that secrete 11,2, IL3, and 11,4 in response to in vitro re-
stimulation . Low levels of IFN-y (8 U/ml) were detected
in supernatants from the highest T cell concentration tested
from control, but not thymectomized mice. When the ap-
proximately two-fold decrease in CD4+ T cell recovery from
thymectomized versus control animals is taken into account,
the reduction in the capacity of thymectomized animals to
generate lymphokine secreting effectors is even more pro-
nounced . In addition, the residual CD4+ T cells producing
IL-2 and IL-3, but not IL-4 from thymectomized mice may
in part represent an adjuvant activation of long-lived helper
T cells or of residual precursor cells, since CFA was used for
KLH immunization.
As expected from previous studies (3), CD4+ T cells iso-
lated from the spleens of the thymectomized KLH-primed
mice exhibited significantly increased levels ofPgp-1, and were
unable to generate lymphokine secreting effector cells in vitro
to polyclonal stimulation with Con A (in the presence of
APC, rIL2 and rIL4), but produced IL2 in response to Con A
plus PMA (not shown) . The fact that CD4+ T cells from
thymectomized mice exhibit a reduced capacity to generate
lymphokine producing T cells in response to either in vivo
or in vitro stimulation suggests that the majority of lym-
phokine secreting effector cells are generated from short-lived,
presumably naive precursor cells .
KLHprimed CD4+ Lymphokine-secreting T Cells Are
MEL14 - . To further characterize the in vivo generated
CD4+ effector cells, we examined their expression ofMEL14,
a lymph node-specific homing receptor that has been reported
to be down-regulated shortly after polyclonal activation ofL
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Figure 5.
￿
Separation of KLH-specific CD4+ lymphokine-secreting T cells on the basis ofME1,14 expression. (A) CD4' lymph node T cells were
isolated from mice primed 4 d previously with KLH. The cells were stained with MED14 and separated into positive and negative subsets using MACS
as described in the Materials and Methods. The dotted histogram (center) represents the stained CD4 * population before separation. (B) ME1,14 posi-
tive and negative subsets were compared to stained, unseparated CD4* T cells for the capacity to produce lymphokines in culture supernatants col-
lected 36 h after in vitro restimulation with KLH-pulsed APC. No 11,5 was detected (not shown).
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￿
Separation of KLH-specific CD4* lymphokine secreting T cells on the basis of CD45RB expression. (A) CD4* lymph node T cells
were isolated from mice primed 5 d previously with KLH. The cells were stained with 23G2 and separated into positive and negative subsets using
MACS as described in theMaterials and Methods. Thedotted histogramrepresents the stained CD4* population before separation. (B) TheCD45RB
positive and negative subsets were compared to stained, unseparated CD4* T cells for lymphokine production in culturesupernatants collected 36 h
after in vitro restimulation with KLH-pulsed APC. No lL5 was detected (not shown).lymph nodeT cells in vitro (16) . MEL14 positive and nega-
tive subsets were isolated by magnetic (MACS) separation
ofCD4+ lymph node T cells from mice primed 4 d previ-
ously with KLH . Before separation, the lymph node CD4+
population consisted predominantly of MEL14+ cells with
moderate levels of staining (dotted histogram, Fig. 5A) . The
MEL14 - subset represented less than 10% of the starting
population but was enriched to 90% by the procedure, as
shown in Fig . 5 A .
Lymphokine production by theMEL14 positive and nega-
tive subsets in response to restimulation with KLH-pulsed
APC isshown in Fig . 5B . The data demonstrate that antigen-
specific production of 1172, IL3, IL-4 and IFN-y was exclu-
sively a property of the MEL14 - cells . IL-5 was not de-
tected . The MEL14+ subset did not suppress the response
of MEL14 - cells to KLH, but was capable of producing
IL2 and IL3 in response to polyclonal activation with Con A
(data not shown), indicating that these cells were not simply
inactivated by staining with MEL14 . In addition, we have
found no effect of MEL14 staining on the function of
CD4+ T cells in assays of helper function or proliferation
(Atkins, G . G ., L . M . Bradley, and S . L . Swain, unpublished
results), CD4+ T cells with intermediate MEL14 staining
have not been examined but comparison with the unsepa-
rated population suggests that the great majority of lym-
phokine production can be attributed to the minor MEL
14 - subset .
KLHprimed CD4+ Lymphokine-secreting T Cells Are Pre-
dominantly CD45RB- . To further characterize the antigen-
specific CD4+ effector population generated in vivo, we ex-
amined expression of CD45RB (23G2) . As shown in Fig.
6 A, unseparated CD4+ lymph node cells from KLH-
primed mice (dotted histogram) contained predominately
23G2+, CD4+ T cells (78%) . The positive and negative
subsets were enriched to greater than95% by magnetic sepa-
ration . In response to in vitro restimulation with KLH-pulsed
APC, the CD45RB- population secreted high levels of IL-2
as well as IL-3, 11,4, and was responsible for virtually all
of the IL4 and IFN-y production (Fig. 6 B) . In contrast,
the CD45RB+ population secreted high levels IL-2 and
moderate levels of IL-3, but not IL4 or IFN-y in response
to antigen stimulation (Fig . 6 B) . However, low numbers
ofCD45RB- cells produced much more IL-2 and IL-3 than
the same number of CD45RB+ cells . No effect of the
CD45RB staining was detected in mixtures of the positive
and negative subsets, and both the CD45RB positive and
negative subsets produced IL2, following polyclonal activa-
tion with Con A (not shown) . The data indicate that the
majority of antigen-specific lymphokine secretion by CD4+
T cells from recently primed mice is associated with the
CD45RB - subset .
Discussion
We have investigated the in vivo development of a popu-
lation of antigen-specific helper-effector T cells and have
characterized them in terms of the patterns and amount of
lymphokines produced, kinetics of response, and surface
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phenotype. Several conclusions can be drawn from these
studies. First, a transient population ofCD4+ T cells which
secretes high titers of IL-2, IL3, and 11.74 develops in the
draining lymph nodes within a few days of injection of an-
tigen . The lymphokine secretion requires antigen-specific re-
stimulation in vitro, and the population can provide excel-
lent helper activity for B cells . Second, the effector population
in this primary response is dependent upon, and likely de-
rives from a short-lived population ofT cells which is depleted
following adult thymectomy and includes cells ofnaive pheno-
type. Third, the effectors are found exclusively in the minor
MEL14 - population of lymph node CD4+ T cells from
primed animals. Effectors which produce IL4 and IFN-'y are
contained exclusively within the CD45RB - subset ofCD4+
T cells and IL2 and IL3 producing effectors are enriched in
this population . A minor portion of IL2 and IL3 secretion
is found among the CD45RB subset .
In this study we analyzed antigen-specific stimulation of
lymphokine production by primed CD4+ T cells in vitro
as well as the kinetics of the development of the responding
population in vivo (Fig. 2 and 3) . Our data do not suggest
that 1172 production precedes that ofIL4, as recently reported
by Mohler and Butler following in vivo sensitization with
picryl chloride (13) . In our study, antigen-specific CD4+ T
cells with the capacity to produce IL-2, IL3, and IL4 by 12 h
following specific restimulation in vitro were apparent as early
as 3 d after immunization withKLH, exhibited peak activity
from 4-7 d, and rapidly declined, thereafter. AlthoughIFN-y
was generally not detected in culture supernatants until 48 h,
enrichment of the lymphokine-producing effector population
on the basis of low expression of MEL14 (Fig . 5 B) or
CD45RB (Fig. 6 B) enabled detection of high titers ofIFN -'Y
in 24 to 36 h supernatants. Since the ELISA assays used to
detect IFN-y and IL5 (which detect 500 pg and 2,000 pg,
respectively) are approximately 10-80 times less sensitive then
the bioassays for IL-2, IL-3 and IL4 (which detect 3 pg of
lymphokine [IL2, IL3] to 50 pg [IL-4]), the low levels of
INF-y probably represent significant production. Because of
the relative insensitivity ofthe ELISA, IL5 may also be pro-
duced at low levels which are not being detected . Similar in
vivo kinetics of effector development have been observed in
the induction of T cells with the capacity to produce IL4
after in vivo priming with goat anti-mouse S (12) . In addi-
tion, we found that effector cells that are generated in re-
sponse to in vivo immunization withSRBC also exhibit peak
activity within 4 to 7 d ofpriming (our unpublished obser-
vations) . These results indicate that the activity of recently
activated effector cells is transient, and suggests that the effector
populationmay be short-lived and represents a primary helper
T cell population that is generated in response to immuni-
zation .
We show here that antigen-primed CD4+ T cells produce
readily detectable quantities of lymphokines, in addition to
IL2, upon in vitro restimulation with antigen (Fig. 1 and
2) . In several previous studies, antigen-primed T cells pro-
duced only 11,2 in response to specific restimulation in vitro
unless cells were expanded in limiting dilution or bulk cul-tures by cycles of rest and restimulation with antigen (4, 5,
11). Several laboratories, including our own have also reported
that lymphokine production which can be detected following
polyclonal or alloantigen activation of freshly isolated CD4+
T cells from normal, unimmunized mice is restricted pri-
marily to 11,2 (3, 4, 8, 25), and have suggested that IL A
production is associated with activated (large, low density)
T cells (26). In vitro polyclonal restimulation of antigen-
primed CD4+ T cells elicits secretion of IL-3, IL,4, and
IFN-y in addition 11,2, analogous to the antigen-specific
effector population described here (8, 12). Although in vivo
generated KLH-specific effectors secreted readily detectable
titers of IL2, IL3, and IL4, and low levels of IFN-,y in re-
sponse to in vitro restimulation with antigen, we did not
assess lymphokine production by individual cells and thus
cannot determine whether subsets analogous to Th-1 and Th-2
cells are generated, and/or whether cells with mixed pheno-
types are represented. However, in other studies of helper
T cell clones derived shortly after immunization with pro-
tein antigens in adjuvant, mixed patterns oflymphokine secre-
tion were predominantly obtained (8-10).
A number of studies of polyclonal activated cells support
the concept that naive T cells only can secrete IL-2 (2, 4, 12)
in response to stimulation but that they can develop, in vitro,
into cells which secrete large quantities of a greater array of
lymphokines. In the response to KLH, we see little evidence
of early IL-2 production presumably because of the low fre-
quency ofKLH-specific T cells in unimmunized animals. The
large increase in IL2 production, as well as production of
IL3 and IL4, that requires in vitro restimulation and that
depends on immunization, is consistent with the concept that
the KLH-specific precursors have expanded greatly over the
5-7-d period and/or been recruited to the lymph node. Since
the efficient development of Ab-secreting cells capable of
production of isotypes other than IgM depends on the pres-
ence of IL-4 and/or IFN-,y, as well as IL-2 (1), the initial IL-2
that could be produced by naive helper T cells would be un-
likely to be sufficient to drive an effective B cell response to
antigen. Thus, it is likely that the development of an effector
population studied here, is a prerequisite for a good B cell
response to an antigen not previously encountered by the an-
imal. The -requirement for restimulation of the CD4+
effectors makes sense in this context, because it would insure
that they would not produce lymphokines until they encoun-
tered the appropriate antigen presented by B lymphocytes or
other APC. Indeed, we have demonstrated that the popula-
tion of lymph node cells, most enriched in effectors provides
excellent help for a B cell response (Fig. 1 B).
The antigen-specific lymphokine producing T cells which
develop in mice recently immunized with KLH are depen-
dent upon, and possibly derived from a short-lived precursor
population that is largely depleted by thymectomy (Fig. 4) .
The studies ofKappler et al. (27) have also shown that adult
thymectomy prevents priming of helper activity in vivo. Adult
thymectomy has been shown to deplete about 50% of
CD4+ T cells that are predominantly of naive phenotype
(Pgp-1 high and CD45RB low), and enrich the reciprocal
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population expressing a memory phenotype which, in con-
trast to the in vivo generated effector population, produces
primarily IL2 and only low levels of 11,3, 11,4, and IFN-T
(3, 28, and results discussed here). We have previously shown
that CD4+ effector cells which develop in vitro are derived
from a short-lived or thymic dependent precursor popula-
tion (3). In this study, we found that, as in the spleen,
CD4+ T cells that express high levels of Pgp-1 are enriched
in the lymph nodes after adult thymectomy, correlating with
the loss of the precursor population that is required for the
generation of antigen-specific effector cells afterprimary im-
munization. Thus the effector cells we have generated in vivo
and in vitro are analogous in this respect as well.
Antigen-specific effector cells generated in vivo are primarily
low in expression of CD45RB and MEL14 (Fig. 5 and 6),
markers which also exhibit a reduced pattern of expression
shortly after activation of T cells in vitro (16, 18). MEL14
is a lymph node-specific homing receptor that is initially ac-
quired by mature thymocytesjust before their exit to the pe-
riphery (21). Recirculating naive T cells are thought to ex-
press MEL14, allowing their extravasation to lymph nodes.
MEL14 is shed by T cells following activation by mitogens
or allogeneic cells in vitro (16). The loss of surface MEL14
correlates in vitro with changes in cell surface glycosylation
of activated lymphocytes found in germinal centers, which
are MEL14 - and unable to home to lymph nodes. B cells
recently activated by antigen in vivo are also MEL14 - (29).
Ifloss ofsurface MEL14 is associated with antigen-activation
in vivo, recirculation patterns of lymphocytes may be altered
and at least temporarily permit localization in sites of an-
tigen concentration during an immune response (30).
Changes in surface expression of CD45R that are induced
by activation of CD4+ T cells arise by alternative splicing
of exons encoding the extracellular domain (31). The exon
B-dependent isoforms of CD45R that are recognized by 23G2
are down-regulated on CD4+ T cells following in vitro ac-
tivation by allogeneic cells (18) as well as on memory CD4+
helper T cells (17). In this study, we demonstrate that
CD4+ effector T cells with the capacity to secrete lym-
phokines shortly after in vivo immunization are predominately
contained within the CD45RB low subset. These data are
thus consistent with in vitro studies showing the loss of
CD45R by CD4+ T cells following antigen-stimulation
(18) . However, heterogeneity of CD4+ effector cells is also
detected on the basis of separation with CD45RB (Fig. 6
B). Although the CD45RB+ effector cells are unable to pro-
duce IL4 or IFN-y, this subset can nonetheless secrete sub-
stantial titers of IL2 and IL3 in response to specific restimu-
lation. In vitro studies of human lymphocytes have shown
that changes in surface expression of CD45R occur over sev-
eral days (31). Thus, it is not clear from this study whether
the CD45RB+ population of antigen-primed CD4+ T cells
represents a distinct subset of effectors, or a population in
transition from CD45RB high-to-low expression. However,
our data indicate that at the peak of antigen-specific effector
development in vivo, transition to a memory surface pheno-
type has largely occurred, yet the effector population can beclearly distinguished from resting memory CD4+ T cells by
the production of distinct arrays of lymphokines.
Our studies on the in vitro generation of CD4+ effector
cells have demonstrated that IL4andIFN-y differentially regu-
late the development of CD4+ subsets with discrete lym-
phokine-secreting phenotypes (22, 32), andother studies sup-
port the directive effects ofIIA and IFN-y in thegeneration
of subsets of helper Tcells (7, 8, 12) . It is important to note
that IL2, thepredominantlymphokine secretedbyboth resting
naive and memory CD4+ T cells in response to polyclonal
activation, exerts no directive effect on the development of
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